436 related articles for article (PubMed ID: 30807655)
1. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options.
Sharma S; Rai KR
Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655
[TBL] [Abstract][Full Text] [Related]
2. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
Iovino L; Shadman M
Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
4. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options.
Yeung CCS; Shadman M
Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069
[TBL] [Abstract][Full Text] [Related]
5. Current Treatment of Chronic Lymphocytic Leukemia.
Jamroziak K; Puła B; Walewski J
Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.
Hilal T; Gea-Banacloche JC; Leis JF
Blood Rev; 2018 Sep; 32(5):387-399. PubMed ID: 29571669
[TBL] [Abstract][Full Text] [Related]
7. [Chronic lymphocytic leukemia: pathophysiology and current therapy].
Takizawa J
Rinsho Ketsueki; 2017; 58(5):471-479. PubMed ID: 28592762
[TBL] [Abstract][Full Text] [Related]
8. New treatment approaches in CLL: Challenges and opportunities in the elderly.
Eichhorst B; Hallek M; Goede V
J Geriatr Oncol; 2016 Sep; 7(5):375-82. PubMed ID: 27491497
[TBL] [Abstract][Full Text] [Related]
9. [State of the art molecular diagnostics and therapy of chronic lymphocytic leukaemia in the era of new targeted therapies].
Gurbity Pálfi T; Fésüs V; Bödör C; Borbényi Z
Orv Hetil; 2017 Oct; 158(41):1620-1629. PubMed ID: 29025288
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia.
Rossi D; Gerber B; Stüssi G
Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579
[TBL] [Abstract][Full Text] [Related]
11. Initial therapy of chronic lymphocytic leukemia.
Eichhorst B; Cramer P; Hallek M
Semin Oncol; 2016 Apr; 43(2):241-50. PubMed ID: 27040702
[TBL] [Abstract][Full Text] [Related]
12. Frontline Therapy of Chronic Lymphocytic Leukemia: Changing Treatment Paradigm.
Sengar M; Jain H; Rajendra A; Rengaraj K; Thorat J
Curr Hematol Malig Rep; 2020 Jun; 15(3):168-176. PubMed ID: 32542586
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia.
Wendtner CM; Gregor M
Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930
[TBL] [Abstract][Full Text] [Related]
14. Management of unfit elderly patients with chronic lymphocytic leukemia.
Eichhorst B; Hallek M; Goede V
Eur J Intern Med; 2018 Dec; 58():7-13. PubMed ID: 30527922
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers and standard management of chronic lymphocytic leukemia.
Stilgenbauer S
Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
[TBL] [Abstract][Full Text] [Related]
16. Tailored Treatment Strategies for Chronic Lymphocytic Leukemia in a Rapidly Changing Era.
Brander D; Islam P; Barrientos JC
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():487-498. PubMed ID: 31099686
[TBL] [Abstract][Full Text] [Related]
17. Management of elderly and unfit patients with chronic lymphocytic leukemia.
Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R
Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157
[TBL] [Abstract][Full Text] [Related]
18. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective.
Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145
[TBL] [Abstract][Full Text] [Related]
19. The future of chronic lymphocytic leukemia: potential directions from ASH 2017.
Molica S
Expert Rev Hematol; 2018 Jun; 11(6):481-486. PubMed ID: 29791237
[TBL] [Abstract][Full Text] [Related]
20. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
Voorhies BN; Stephens DM
Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
